Biotech · Private company
Nalo Therapeutics Inc.
Track this companyFree. Adds Nalo Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- NX-019Phase 1 · EGFR Mutation-Related TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 5, 2022ClinicalTrials.gov NCT05514496 · fetched Nov 12, 2026